Literature DB >> 10889329

The pyrrole moiety as a template for COX-1/COX-2 inhibitors.

G Dannhardt1, W Kiefer, G Krämer, S Maehrlein, U Nowe, B Fiebich.   

Abstract

Aroyl- and thiophene-substituted pyrrole derivatives have been synthesized as a new class of COX-1/COX-2 inhibitors. The inhibition of COX-1 was evaluated in a biological system using bovine PMNLs as the enzyme source, whereas LPS-stimulated human monocytes served as the enzyme source for inducible COX-2. The determination of the concentration of arachidonic acid metabolites was performed by HPLC for COX-1 and RIA for COX-2. Variation of the substitution pattern led to a series of active compounds which showed inhibition for COX-1 and COX-2. Structural requirements for the development of COX-1/COX-2 inhibitors are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889329     DOI: 10.1016/s0223-5234(00)00150-1

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  13 in total

1.  Synthesis of Deuterated Benzopyran Derivatives as Selective COX-2 Inhibitors with Improved Pharmacokinetic Properties.

Authors:  Yanmei Zhang; Micky D Tortorella; Yican Wang; Jianqi Liu; Zhengchao Tu; Xiaorong Liu; Yang Bai; Dingsheng Wen; Xin Lu; Yongzhi Lu; John J Talley
Journal:  ACS Med Chem Lett       Date:  2014-07-27       Impact factor: 4.345

2.  Crystal structures of methyl 3-(4-iso-propyl-phen-yl)-1-methyl-1,2,3,3a,4,9b-hexa-hydro-thio-chromeno[4,3-b]pyrrole-3a-carboxyl-ate, methyl 1-methyl-3-(o-tol-yl)-1,2,3,3a,4,9b-hexa-hydro-thio-chromeno[4,3-b]pyrrole-3a-carboxyl-ate and methyl 1-methyl-3-(o-tol-yl)-3,3a,4,9b-tetra-hydro-1H-thio-chromeno[4,3-c]isoxazole-3a-carboxyl-ate.

Authors:  R Raja; M Suresh; R Raghunathan; A SubbiahPandi
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-05-07

3.  Novel synthesis and antitumor evaluation of polyfunctionally substituted heterocyclic compounds derived from 2-cyano-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-acetamide.

Authors:  Hoda Z Shams; Rafat M Mohareb; Maher H Helal; Amira E Mahmoud
Journal:  Molecules       Date:  2010-12-27       Impact factor: 4.411

4.  Pyrrole and Fused Pyrrole Compounds with Bioactivity against Inflammatory Mediators.

Authors:  Samar Said Fatahala; Sherifa Hasabelnaby; Ayman Goudah; Ghada I Mahmoud; Rania Helmy Abd-El Hameed
Journal:  Molecules       Date:  2017-03-17       Impact factor: 4.411

Review 5.  Raging the War Against Inflammation With Natural Products.

Authors:  Ali Attiq; Juriyati Jalil; Khairana Husain; Waqas Ahmad
Journal:  Front Pharmacol       Date:  2018-09-07       Impact factor: 5.810

6.  [3+2] Cycloaddition of Tosylmethyl Isocyanide with Styrylisoxazoles: Facile Access to Polysubstituted 3-(Isoxazol-5-yl)pyrroles.

Authors:  Xueming Zhang; Xianxiu Xu; Dawei Zhang
Journal:  Molecules       Date:  2017-07-07       Impact factor: 4.411

7.  Methyl 4-(tri-fluoro-meth-yl)-1H-pyrrole-3-carboxyl-ate.

Authors:  P A Suchetan; S Sreenivasa; B S Palakshamurthy; K E Manojkumar; S Madan Kumar; N K Lokanath
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-09-18

8.  Facile and promising method for michael addition of indole and pyrrole to electron-deficient trans-β-nitroolefins catalyzed by a hydrogen bond donor catalyst Feist's acid and preliminary study of antimicrobial activity.

Authors:  Abdullah M A Al Majid; Mohammad Shahidul Islam; Assem Barakat; Mohamed H M Al-Agamy; Mu Naushad
Journal:  ScientificWorldJournal       Date:  2014-01-16

9.  Microwave Assisted Synthesis, Pharmacological Activities, and Molecular Docking Studies of Ethyl 2-[2-Substituted-4-(Thiophenyl) Thiazolyl] Acetates.

Authors:  Mahesh Veerabhadra Attimarad; Mohammed Abdou Khedr; Bandar Essa Aldhubiab
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

Review 10.  Synthesis of Multi-Substituted Pyrrole Derivatives Through [3+2] Cycloaddition with Tosylmethyl Isocyanides (TosMICs) and Electron-Deficient Compounds.

Authors:  Zhengning Ma; Zicheng Ma; Dawei Zhang
Journal:  Molecules       Date:  2018-10-17       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.